Navigation Links
American Oriental Bioengineering Reports First Quarter 2011 Financial Results
Date:5/9/2011

NEW YORK, May 9, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), (the "Company" or "AOB"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over–the-counter ("OTC") products, today announced financial results for the first quarter ended March 31, 2011.

First Quarter 2011 Financial PerformanceIn the first quarter of 2011, revenue decreased to $52.0 million from $53.7 million in the same period of 2010.

  • The Company generated revenue of $48.7 million from its manufacturing business in the first quarter of 2011 compared with $50.5 million in the prior year period.  Revenue from pharmaceutical products decreased 4.7% to $39.0 million from $40.9 million in the prior year period. Nutraceutical products generated revenue of approximately $9.8 million in the first quarter of 2011, an increase of 1.2% from $9.7 million in the prior year period.  The revenue performance reflects the combined results of the Company's continuous marketing efforts, new product launches, and expanding coverage in rural areas.  This was offset by the impact from the Company's strategic shift of revenue mix toward higher-margin products to minimize the impact from the increased costs of certain raw materials.
  • The Company generated $3.3 million from its distribution business, Nuo Hua, in the first quarter of 2011, compared to $3.2 million in the prior year period.

  • Gross profit in the first quarter of 2011 was $25.1 million compared to $28.2 million in the first quarter of 2010. Gross margin was 48.2% compared to 52.5% in the prior year period.  The margin pressure was mainly caused by a higher proportion of generic product sales in the rural market, the increased costs of certain raw materials, as well as the new le
    '/>"/>

    SOURCE American Oriental Bioengineering, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. American Laser Centers Opens Three Minneapolis-St. Paul Area Clinics
    2. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
    3. Bacon Eating Contest Raises Money for American Heart Association
    4. Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes
    5. ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems
    6. American Oriental Bioengineering Announces Participation in September Investor Conferences
    7. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
    8. PLC Systems Receives Delisting Notice From American Stock Exchange
    9. Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Arent Risk Takers
    10. Best Practices Document on Cryoablation Posted on Website of American Urological Association
    11. Tips from the journals of the American Society for Microbiology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... In today,s fast changing healthcare environment, ... positive health outcomes, improve profitability and enhance their ... in their communities. At ThoughtSpot 2015, Good ... announced a new set of innovative capabilities that ... help independent pharmacies endure the industry,s most pressing ...
    (Date:7/31/2015)... ... July 31, 2015 , ... ... market analysis and premium industry insights on the global resorcinol industry. The report ... collective study of vivid market scenarios and analysis of primary and secondary inputs ...
    (Date:7/31/2015)... -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or ... of cord blood collection, laboratory testing, hematopoietic stem cell ... the Company has filed its Annual Report on Form ... filed Form 20-F includes audited financial statements for the ... can be accessed by visiting the U.S. Securities and ...
    (Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm ... quantification of partially hydrolyzed gluten in foods, has been accepted by AOAC International ... “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on ...
    Breaking Biology Technology:AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
    ... ITMN ) today announced that five abstracts from clinical ... programs related to the hepatitis C virus (HCV) have been ... European Association for the Study of the Liver (EASL, April ... to be available at www.easl.ch . ITMN-191 is ...
    ... David P. Wright, Co-Chair of the Alliance ... Inc., testified today before the House Labor, Health ... the critical importance of developing drugs, vaccines and ... bioterrorism and other catastrophic health emergencies. Effective medical ...
    ... BBK Worldwide to Better Serve Asia-Pacific Clinical Trial ... a global leader in patient recruitment for clinical ... -- Osaka, G.K., in Osaka, Japan. The company ... and medical device companies, as well as CROs ...
    Cached Biology Technology:InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting 2InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting 3Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development 2Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace 2Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace 3
    (Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
    (Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
    (Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "Capacitive Fingerprint ... To this date, fingerprint sensing technology ... and fingerprint sensors are well developed. This patent ... technology. The domain of capacitive fingerprint ...
    Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
    ... Bucknell University biology professor Chris Martine has discovered and ... Lost City. Martine, who named the plant Solanum cowiei ... PhytoKeys . Martine described the plant as "gender ... male by producing pollen. "What they,re really doing ...
    ... Current pledges for greenhouse gas emission reductions are ... reach internationally agreed climate targets, according to new ... research teams coordinated by the International Institute for ... for Climate Impacts Research (PIK)., In the absence ...
    ... alcohol severely disrupts major features of brain development ... motor function, conditions typical in humans with Fetal ... the University of California, Riverside. In a ... prenatal exposure to alcohol significantly altered the expression ...
    Cached Biology News:Unlikely collaboration leads to discovery of 'gender-bending' plant 2Unlikely collaboration leads to discovery of 'gender-bending' plant 3Continuing with pledge pathways to 2030 could push climate goals out of reach 2Prenatal exposure to alcohol disrupts brain circuitry 2Prenatal exposure to alcohol disrupts brain circuitry 3
    Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
    Concentration: 1mg/ml. Antigen: Propidium Iodide ...
    Anti-Mouse Qa.m7, Ascites (Clone 5035-50.1) (mouse IgM)...
    Barcoded Slides, 5 Packs of 5 Slides (25/Case)...
    Biology Products: